Integrated Flow Development at PharmaBlock
Transitioning from Batch to Continuous Flow: Scaled-Up Solutions for High-Risk Reactions
Program Overview
- Evaluate the direct impact of batch-to-flow transformation on cost, sustainability, and key performance indicators
- Discover practical technical solutions to mitigate thermal runaway, poor mass transfer, and strict material selection challenges across extreme temperature and pressure ranges.
- Learn how to combine kinetic modeling, CFD simulation, inline Raman analytics, and Bayesian closed-loop intelligent optimization to automate and support industrial scale-up.
Moving from traditional batch production to continuous flow chemistry offers massive efficiency gains, but navigating scale-up bottlenecks can be daunting.
In this technical webinar, Aimin Jiang from the PharmaBlock Research Institute (PBRI) presents, Integrated Flow Development at PharmaBlock, breaking down their end-to-end integrated continuous flow development system. Built on robust cross-disciplinary collaboration, this system leverages engineering, computational modeling, and real-time analytical monitoring to successfully scale hazardous and complex chemistry.
Target audience
Process Chemists and Chemical Engineers
R&D Directors and Lab Managers
Pharma and Agrochemical Development Scientists
Automation and Analytical Technology Specialists
About the Presenter
Aimin Jiang
PharmaBlock
Boasting 15 years of end-to-end experience in lab-scale R&D, process development and manufacturing of pharmaceutical building blocks, Aimin Jiang has profound expertise in continuous flow process development and scale-up production. He has successfully delivered over 200 kilogram-scale and higher pharmaceutical building block manufacturing projects during his tenure. As a core member of PharmaBlock’s professional process development team, he has long been involved in team building and daily operational management, gaining solid and comprehensive experience in overall project management.
